321 related articles for article (PubMed ID: 32433508)
21. Acute lymphoblastic leukemia and chromosome 21.
Berger R
Cancer Genet Cytogenet; 1997 Mar; 94(1):8-12. PubMed ID: 9078285
[TBL] [Abstract][Full Text] [Related]
22. Hematological disorders and leukemia in children with Down syndrome.
Bruwier A; Chantrain CF
Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227
[TBL] [Abstract][Full Text] [Related]
23. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
[TBL] [Abstract][Full Text] [Related]
24. Myeloid leukemia in Down syndrome.
Khan I; Malinge S; Crispino J
Crit Rev Oncog; 2011; 16(1-2):25-36. PubMed ID: 22150305
[TBL] [Abstract][Full Text] [Related]
25. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
[TBL] [Abstract][Full Text] [Related]
26. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia.
Kearney L; Gonzalez De Castro D; Yeung J; Procter J; Horsley SW; Eguchi-Ishimae M; Bateman CM; Anderson K; Chaplin T; Young BD; Harrison CJ; Kempski H; So CW; Ford AM; Greaves M
Blood; 2009 Jan; 113(3):646-8. PubMed ID: 18927438
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
[TBL] [Abstract][Full Text] [Related]
28. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
Shim KS; Ferrando-Miguel R; Lubec G
J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
[TBL] [Abstract][Full Text] [Related]
29. ETS family of genes in leukemia and Down syndrome.
Papas TS; Watson DK; Sacchi N; Fujiwara S; Seth AK; Fisher RJ; Bhat NK; Mavrothalassitis G; Koizumi S; Jorcyk CL
Am J Med Genet Suppl; 1990; 7():251-61. PubMed ID: 2149958
[TBL] [Abstract][Full Text] [Related]
30. Down syndrome and leukemia: from basic mechanisms to clinical advances.
Baruchel A; Bourquin JP; Crispino J; Cuartero S; Hasle H; Hitzler J; Klusmann JH; Izraeli S; Lane AA; Malinge S; Rabin KR; Roberts I; Ryeom S; Tasian SK; Wagenblast E
Haematologica; 2023 Oct; 108(10):2570-2581. PubMed ID: 37439336
[TBL] [Abstract][Full Text] [Related]
31. The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome.
Lanza C; Volpe G; Basso G; Gottardi E; Perfetto F; Cilli V; Spinelli M; Ricotti E; Guerrasio A; Madon E; Saglio G
Leukemia; 1997 Jun; 11(6):820-1. PubMed ID: 9177434
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML(M7).
Ives JH; Dagna-Bricarelli F; Basso G; Antonarakis SE; Jee R; Cotter F; Nizetić D
Genes Chromosomes Cancer; 1998 Sep; 23(1):61-6. PubMed ID: 9713998
[TBL] [Abstract][Full Text] [Related]
33. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Xavier AC; Ge Y; Taub JW
J Mol Diagn; 2009 Sep; 11(5):371-80. PubMed ID: 19710397
[TBL] [Abstract][Full Text] [Related]
34. Trisomy 21 leukemias: finding the hits that matter.
Rabson AB
Oncogene; 2010 Nov; 29(46):6099-101. PubMed ID: 20711238
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic and molecular studies of Down syndrome individuals with leukemia.
Shen JJ; Williams BJ; Zipursky A; Doyle J; Sherman SL; Jacobs PA; Shugar AL; Soukup SW; Hassold TJ
Am J Hum Genet; 1995 Apr; 56(4):915-25. PubMed ID: 7717402
[TBL] [Abstract][Full Text] [Related]
36. Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
Taub JW; Matherly LH; Stout ML; Buck SA; Gurney JG; Ravindranath Y
Blood; 1996 Apr; 87(8):3395-403. PubMed ID: 8605357
[TBL] [Abstract][Full Text] [Related]
37. [Constitutional chromosome abnormalities and leukemia].
Berger R
Nouv Rev Fr Hematol; 1970; 10(1):99-107. PubMed ID: 4246340
[No Abstract] [Full Text] [Related]
38. Down syndrome, drug metabolism and chromosome 21.
Taub JW; Ge Y
Pediatr Blood Cancer; 2005 Jan; 44(1):33-9. PubMed ID: 15390307
[TBL] [Abstract][Full Text] [Related]
39. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis.
Attarbaschi A; Mann G; König M; Dworzak MN; Trebo MM; Mühlegger N; Gadner H; Haas OA;
Leukemia; 2004 Oct; 18(10):1611-6. PubMed ID: 15356655
[TBL] [Abstract][Full Text] [Related]
40. Trisomy 21 in neoplastic cells.
Mitelman F; Heim S; Mandahl N
Am J Med Genet Suppl; 1990; 7():262-6. PubMed ID: 2149959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
